Trial Profile
Phase I trial of intratumoral pIL-12 [gene therapy] electroporation in malignant melanoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Tavokinogene telseplasmid (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 19 Apr 2016 Results of retrospective analysis of long-term, follow-up data published in an OncoSec media release.
- 19 Apr 2016 Results of retrospective analysis of long-term, follow-up data were presented at the the American Association of Cancer Research (AACR) Annual Meeting 2016, according to an OncoSec Medical media release.
- 07 May 2015 According to an OncoSec Medical media release, data from this study were presented at the 11th Annual PEGS Conference.